Q32 Bio Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Q32 Bio Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $111.44M.
- Q32 Bio Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-12-31 was -$160.00.
- Q32 Bio Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-09-30 was $0.00.
- Q32 Bio Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $111.44M.
- Q32 Bio Inc. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $137.76M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $111.44M 10-K · filed 2026-03-10 | |
| 2024-03-31 | $111.44M 10-Q · filed 2025-11-13 | |
| 2018-12-31 | -$160.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $137.76M 10-K · filed 2019-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 |